Integrated BioPharma, Inc. (OTCMKTS:INBP) Sees Significant Growth in Short Interest

Integrated BioPharma, Inc. (OTCMKTS:INBP) was the recipient of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 6,400 shares, a growth of 23.1% from the October 31st total of 5,200 shares. Based on an average daily volume of 13,900 shares, the days-to-cover ratio is presently 0.5 days.

Integrated BioPharma Stock Down 1.2 %

Shares of INBP traded down $0.00 during mid-day trading on Monday, hitting $0.32. The company had a trading volume of 7,031 shares, compared to its average volume of 10,587. Integrated BioPharma has a 1-year low of $0.16 and a 1-year high of $0.35. The business’s 50-day simple moving average is $0.29 and its 200-day simple moving average is $0.24. The stock has a market cap of $9.63 million, a PE ratio of 16.00 and a beta of 0.62.

Integrated BioPharma (OTCMKTS:INBP) last issued its earnings results on Friday, September 20th. The company reported $0.01 earnings per share for the quarter. Integrated BioPharma had a return on equity of 2.26% and a net margin of 0.84%. The business had revenue of $12.75 million for the quarter.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.